Benzinga | Feb 24, 2021 07:11AM EST

Horizon Therapeutics Q4 Adj. EPS $1.28 Beats $1.05 Estimate, Sales $745.30M Beat $690.03M Estimate

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.05 by 21.9 percent. This is a 128.57 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $745.30 million which beat the analyst consensus estimate of $690.03 million by 8.01 percent. This is a 105.01 percent increase over sales of $363.55 million the same period last year.